Table: Personalized Cancer Vaccine Trials in the United States
Table: Personalized Cancer Vaccine Trials in the United States

Table: Personalized Cancer Vaccine Trials in the United States

There are currently more than two dozen ongoing Phase 1 and Phase 2 trials using different vaccine platforms such as DNA, RNA, synthetic long peptides, and dendritic cells.

Jasreet Hundal and Elaine R. Mardis
Jul 15, 2019

ABOVE: © ISTOCK.COM, JURGAR

Research into personalized cancer vaccines is booming. Explore the ongoing clinical trials in the country in the list below.

Trial ID
 PhaseCancer typeInstitution/ Company SponsorsVaccine PlatformPatient StatusPatient Accrual Target
NCT03568058Phase 1Advanced cancersUniversity of California, San DiegoSynthetic long peptideRecruiting10
NCT03199040Phase 1Breast cancerWashington University School of Medicine, MedImmuneDNARecruiting24
NCT02348320Phase 1Breast cancerWashington University School of MedicineDNARecruiting30
NCT03121677Phase 1Follicular lymphomaWashington University School of Medicine, Bristol-Myers SquibbSynthetic long peptideRecruiting20
NCT03122106Phase 1Pancreatic cancerWashington University School of Medicine, National Cancer Institute (NCI)DNARecruiting15
NCT03532217Phase 1Prostate cancerWashington University School of Medicine, Bristol-Myers SquibbDNARecruiting20
NCT03598816Phase 2Renal cell carcinomaWashington University School of Medicine, MedImmuneDNANot yet recruiting48
NCT03068832Phase 1...

Read the full story.

Interested in reading more?

On Target July Issue The Scientist

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?